| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/06/1997 | WO1997003710A1 Wound treatment composition |
| 02/06/1997 | WO1997003702A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | WO1997003700A2 Gamma-interferon activity modulating agent |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003698A1 Hormone patch |
| 02/06/1997 | WO1997003692A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | WO1997003688A1 Pharmaceutical compositions containing protein |
| 02/06/1997 | WO1997003685A1 Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
| 02/06/1997 | WO1997003683A1 Treatment of scleroderma and related diseases |
| 02/06/1997 | WO1997003676A1 Novel pharmaceutical formulation of dehydroepiandrosterone for percutaneous topical application |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003655A1 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
| 02/06/1997 | WO1997003654A2 Pharmaceutical compositions |
| 02/06/1997 | WO1997003651A1 Lipid vehicle drug delivery composition containing vitamin e |
| 02/06/1997 | WO1997003629A1 Drug delivery compositions for improved stability of steroids |
| 02/06/1997 | WO1996041608A3 Pyrularia thionin containing immunotoxins and immunotoxin-like conjugates |
| 02/06/1997 | WO1996041144A3 Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
| 02/06/1997 | WO1996040074A3 Device for releasing aggregation-stabilized, biologically active agent |
| 02/06/1997 | WO1996040042A3 Stabilized steroid compositions |
| 02/06/1997 | CA2227538A1 Hormone patch |
| 02/06/1997 | CA2227287A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2226523A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | CA2224734A1 Lipid vehicle drug delivery composition containing vitamin e |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0756868A2 Aerosol compositions |
| 02/05/1997 | EP0756863A1 Preparation process of a composition containing a heat-sensitive compound and the composition obtained thereby |
| 02/05/1997 | EP0756820A2 Compositions comprising an iodosphor of Poly-N-vinyllactam and dextrin and usetheref |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756601A1 Compositions and methods for cell transformation |
| 02/05/1997 | EP0756496A1 Dendrimeric compounds |
| 02/05/1997 | EP0756494A1 Modified insulin-like growth factors |
| 02/05/1997 | EP0756493A1 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base |
| 02/05/1997 | EP0756489A1 Cyclosporin containing composition and process for the preparation thereof |
| 02/05/1997 | EP0756482A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 02/05/1997 | EP0474647B1 Method and device for the release of drugs to the skin |
| 02/05/1997 | CN1141810A Viral vaccine |
| 02/05/1997 | CN1141808A Interferon solution |
| 02/04/1997 | US5599928 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599924 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/04/1997 | US5599923 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599912 Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances |
| 02/04/1997 | US5599907 Production and use of multimeric hemoglobins |
| 02/04/1997 | US5599852 Polylactone homo- and copolymers |
| 02/04/1997 | US5599843 Visibly reducing wrinkles by applying mixtures containing 2-hydroxy-2-phenyl-propionic acid |
| 02/04/1997 | US5599808 Aqueous indolocarbazole solutions |
| 02/04/1997 | US5599800 High viscosity oil in water emulsion having polysiloxane in oil phase |
| 02/04/1997 | US5599798 Cyclic AMP derivative-containing ointment |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | US5599686 Oligopeptide comprising sequence of amino acids recognized and selectively proteolytically cleaved by free prostate specific antigen |
| 02/04/1997 | US5599557 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 02/04/1997 | US5599555 Encapsulated cometic compositions |
| 02/04/1997 | US5599553 Polycaprolactone film, active material; sustained release |
| 02/04/1997 | US5599552 Biodegradable polymer composition |
| 02/04/1997 | US5599534 Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use |
| 02/04/1997 | US5599528 Preventing discoloration and decomposition of kojic acid in aqueous cosmetic emulsions by adding nonionic surfactants and controlling hydrophilic-lipophilic balance |
| 02/04/1997 | CA2104045C Physical trapping type polymeric micelle drug preparation |
| 02/04/1997 | CA2071840C Method for producing protein microspheres |
| 02/04/1997 | CA2035693C Syrup composition |
| 02/04/1997 | CA1338889C Morphine containing composition |
| 02/01/1997 | CA2181933A1 Formulations containing an iodophore comprising poly-n-vinyl-lactam and dextrin and the use of such formulations |
| 01/30/1997 | WO1997003016A1 Fine particles of petaloid porous hydroxyapatite and process for producing the same |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002827A1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts |
| 01/30/1997 | WO1997002810A2 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | WO1997002759A1 Stabilisation of flavourants |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | CA2223884A1 Polymeric lamellar substrate particles for drug delivery |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755672A1 Silicon composition containing a water-sensitive agent |
| 01/29/1997 | EP0755270A1 Microcapsules, method of making and their use |
| 01/29/1997 | EP0755269A1 Contrast agents |
| 01/29/1997 | EP0755267A1 COMPOSITION CONTAINING OMEGA 3 AND/OR OMEGA 6 POLYUNSATURATED ACIDS HAVING FROM 12 to 22 CARBON ATOMS |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755256A1 Starch-metal complexes for skin and hair |
| 01/29/1997 | EP0755253A1 Intranasal antimigraine composition |
| 01/29/1997 | EP0755246A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
| 01/29/1997 | EP0727978A4 Topical aromatic releasing compositions |
| 01/29/1997 | EP0656777B1 Ready-to-inject azosemide solutions |
| 01/29/1997 | EP0653990B1 Timing valve for the discontinuous metering of a volume flow |
| 01/29/1997 | EP0565706B1 Water-soluble delivery systems for hydrophobic liquids |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141650A Macroencapsulated secretory cells |
| 01/29/1997 | CN1141592A Pharmaceutical prepn. contg. plasminogen activators |
| 01/29/1997 | CN1141589A Film coated tablet of paracetamol and domperidone |
| 01/29/1997 | CN1141168A Controlled release of steroids from sugar coattings |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597829 Anticancer agent |
| 01/28/1997 | US5597802 In combination with an osmolyte and a stabilizer in a buffered solution; enhances animal growth |
| 01/28/1997 | US5597797 Administering growth hormone and insulin-like growth factor |
| 01/28/1997 | US5597608 Feedstock subjected to force and heating conditions to induce flash flow; foods, drugs |
| 01/28/1997 | US5597584 Method of controlling release of an active or drug from a silicone rubber matrix |
| 01/28/1997 | US5597583 Ibuprofen-cyclodextrin complex for oral administration in hot water |
| 01/28/1997 | US5597582 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 01/28/1997 | US5597579 Absorbable surgical device, i.e. sutures |
| 01/28/1997 | US5597578 TGF-β protein compositions for inhibition of cell proliferation |